Insulin-like growth factor I (CA) repeats are associated with higher melanoma's Breslow index but not associated with the presence of the melanoma. A pilot study

Clinica Chimica Acta

Volumn 390, Issue 1-2, 2008, Pages 104-109

  Santonocito, Concetta ^a   Paradisi, Andrea ^a   Capizzi, Rodolfo ^a   Concolino, Paola ^a   Lavieri, Maria Michela ^a   Lanza Silveri, Sara ^a   De Luca, Daniele ^a   Catricalà, Caterina ^b   Di Carlo, Aldo ^b   Zuppi, Cecilia ^a   Ameglio, Franco ^a   Capoluongo, Ettore ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b SAN GALLICANO DERMATOLOGICAL INSTITUTE   (Italy)

Author keywords

Breslow index; IGF I, IGF I(CA) repeats; Malignant melanoma

Indexed keywords

DNA; SOMATOMEDIN C;

ADULT; AGED; ARTICLE; BODY MASS; BREAST CANCER; BRESLOW INDEX; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GENE MUTATION; GENOTYPE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MELANOMA; NUCLEOTIDE REPEAT; PAH GENE; PILOT STUDY; PMCH GENE; PRIORITY JOURNAL; PROSTATE CANCER; SCORING SYSTEM; STATISTICAL SIGNIFICANCE;

ADULT; AGED; BASE SEQUENCE; DNA PRIMERS; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MELANOMA; MIDDLE AGED; PILOT PROJECTS; POLYMORPHISM, GENETIC;

EID: 39649099552     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2008.01.006     Document Type: Article

References (32)

1. Rosen C.J. Serum insulin-like growth factors and insulin-like growth factor-binding proteins: Clinical implications. Clin Chem 45 (1999) 1384-1390
2. Collett-Solberg P.F., and Cohen P. The role of the insulin-like growth factor binding proteins and the IGFBP proteases in modulating IGF action. Endocrinol Metab Clin N Am 25 (1996) 591-614
3. Firth S.M., and Baxter R.C. Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev 23 (2002) 824-854
4. Bruning P.F., Van Doorn J., BonfrÃ̈r J.M., et al. Insulin like growth-factor-binding protein 3 is decreased in early-stage operable pre-menopausal breast cancer. Int J Cancer 62 (1995) 266-270
5. Hankinson S.E., Willett W.C., Colditz G.A., et al. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet 351 (1998) 1393-1396
6. Chan J.M., Stampfer M.J., Giovannucci E., et al. Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science 279 (1998) 563-566
7. Giovannucci E., Pollak M.N., Platz E.A., et al. A prospective study of plasma insulin-like growth factor-1 and binding protein-3 and risk of colorectal cancer in women. Cancer Epidemiol Biomark Prev 9 (2000) 345-349
8. Yu H., Spitz M.R., and Mistry J. Plasma levels of insulin-like growth factor-I and lung cancer risk: a case-control analysis. J Natl Cancer Inst 91 (1999) 151-156
9. Deal C., Ma J., Wilkin F., et al. Novel promoter polymorphism in insulin-like growth factor-binding protein-3: correlation with serum levels and interaction with known regulators. J Clin Endocrinol Metab 86 (2001) 1274-1280
10. Yu H., Li B.D., Smith M., Shi R., Berkel H.J., and Kato I. Polymorphic CA repeats in the IGF-I gene and breast cancer. Breast Cancer Res Treat 70 (2001) 117-122
11. Friedrichsen D.M., Hawley S., Shu J., et al. IGF-I and IGFBP-3 polymorphisms and risk of prostate cancer. Prostate 65 (2005) 44-51
12. Wen W., Gao Y.T., Shu X.O., et al. Insulin-like growth factor-I gene polymorphism and breast cancer risk in Chinese women. Int J Cancer 113 (2005) 307-311
13. Kato I., Eastham J., Li B., Smith M., and Yu H. Genotype-phenotype analysis for the polymorphic CA repeat in the insulin-like growth factor-I (IGF-I) gene. Eur J Epidemiol 18 (2003) 203-209
14. Edmondson S.R., Russo V.C., McFarlane A.C., Wraight C.J., and Werther G.A. Interactions between growth hormone, insulin-like growth factor I, and basic fibroblast growth factor in melanocyte growth. Clin Endocrinol Metab 84 (1999) 1638-1644
15. Satyamoorthy K., Li G., Vaidya B., Kalabis J., and Herlyn M. Insulin-like growth factor-I-induced migration of melanoma cells is mediated by interleukin-8 induction. Cell Growth Differ 13 (2002) 87-93
16. Fleming M.G., Howe S.F., and Graf L.H. Expression of insulin-like growth factor I (IGF-I) in nevi and melanomas. Am J Dermatopathol 16 (1994) 383-3891
17. Rodeck U., Melber K., Kath R., et al. Constitutive expression of multiple growth factor genes by melanoma cells but not normal melanocytes. J Invest Dermatol 97 (1991) 20-26
18. Argenziano G., Fabbrocini G., Carli P., De Giorgi V., Sammarco E., and Delfino M. Epiluminescence microscopy for the diagnosis of doubtful melanocytic skin lesions. Comparison of the ABCD rule of dermatoscopy and a new 7-point checklist based on pattern analysis. Arch Dermatol 134 (1998) 1563-1570
19. Santonocito C., Capizzi R., Concolino P., et al. Association between cutaneous melanoma, Breslow thickness and vitamin D receptor BsmI polymorphism. Br J Dermatol 156 (2007) 277-282
20. Wagner K., Hemminki K., Israelsson E., et al. Polymorphisms in the IGF-1 and IGFBP-3 promoter and the risk of breast cancer. Breast Cancer Res Treat 92 (2005) 133-140
21. Tsuchiya N., Wang L., Horikawa Y., et al. CA repeat polymorphism in the insulin-like growth factor-I gene is associated with increased risk of prostate cancer and benign prostatic hyperplasia. Int J Oncol 26 (2005) 225-231
22. Rosen C.J., Kurland E.S., Vereault D., et al. Association between serum insulin growth factor-I (IGF-I) and a simple sequence repeat in IGF-I gene: implications for genetic studies of bone mineral density. J Clin Endocrinol Metab 83 (1998) 2286-2290
23. Rodriguez S., Gaunt T.R., and Day I.N. Molecular genetics of human growth hormone, insulin-like growth factors and their pathways in common disease. Hum Genet 122 1 (2007) 1-21
24. Jernström H., Sandberg T., Bågeman E., Borg A., and Olsson H. Insulin-like growth factor-1 genotype predicts breast volume after pregnancy and hormonal contraception and is associated with circulating insulin-like growth factor-1 levels: implications for risk of early-onset breast cancer in young women from hereditary breast cancer families. Int J Gynecol Cancer 16 Suppl 2 (2006) 497
25. Molica S., Vitelli G., Mirabelli R., et al. Serum levels of syndecan-1 in B-cell chronic lymphocytic leukemia: correlation with the extent of angiogenesis and disease-progression risk in early disease. Leuk Lymphoma 47 (2006) 1034-1040
26. Shen Q., Lantvit D.D., Lin Q., et al. Advanced rat mammary cancers are growth hormone dependent. Endocrinology 148 10 (2007) 4536-4544
27. Capoluongo E., Zuppi C., and Ameglio F. IGF-1 system, Vitamin D and blood pressure relationships. Cytokine 37 (2007) 183-184
28. Capoluongo E., Ameglio F., Lulli P., et al. Epithelial lining fluid free IGF-I-to-PAPP-A ratio is associated with bronchopulmonary dysplasia in preterm infants. Am J Physiol Endocrinol Metab 292 (2007) E308-E313
29. Capoluongo E., Pitocco D., Santonocito C., et al. Association between serum free IGF-I and IGFBP-3 levels in type-I diabetes patients affected with associated autoimmune diseases or diabetic complications. Eur Cytokine Netw 17 (2006) 167-174
30. Capoluongo E., Vento G., Ameglio F., et al. Increased levels of IGF-1 and beta2-microglobulin in epithelial lining fluid of preterm newborns developing chronic lung disease. effects of rhG-CSF. Int J Immunopathol Pharmacol 19 (2006) 57-66
31. Hoogduijn M.J., Ancans J., Suzuki I., Estdale S., and Thody A.J. Melanin-concentrating hormone and its receptor are expressed and functional in human skin. Biochem Biophys Res Commun 296 (2002) 698-701
32. Schallreuter K.U., Wazir U., Kothari S., et al. Human phenylalanine hydroxylase is activated by H2O2: a novel mechanism for increasing the L-tyrosine supply for melanogenesis in melanocytes. Biochem Biophys Res Commun 322 (2004) 88-92